Symbols / OHI Stock $47.33 -1.25% Omega Healthcare Investors, Inc.

Real Estate • REIT - Healthcare Facilities • United States • NYQ
OHI (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Real Estate
Industry REIT - Healthcare Facilities
CEO Mr. C. Taylor Pickett CPA
Exch · Country NYQ · United States
Market Cap 14.76B
Enterprise Value 18.78B
Income 615.87M
Sales 1.24B
FCF (ttm) 508.25M
Book/sh 17.53
Cash/sh 0.09
Employees 69
Insider 10d —
IPO Aug 07, 1992
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 129.47%
P/E 22.86
Forward P/E 22.92
PEG 11.99
P/S 11.94
P/B 2.70
P/C —
EV/EBITDA 16.71
EV/Sales 15.19
Quick Ratio 0.31
Current Ratio 0.56
Debt/Eq 81.51
LT Debt/Eq —
EPS (ttm) 2.07
EPS next Y 2.06
EPS Growth 39.30%
Revenue Growth 16.70%
EPS Gr Q/Q 38.50%
Rev Gr Q/Q —
Earnings (next) 2026-04-28
Earnings (prior) 2026-04-28
ROA 4.98%
ROE 12.63%
ROIC —
Gross Margin 99.30%
Oper. Margin 64.12%
Profit Margin 51.14%
Shs Outstand 297.80M
Shs Float 296.82M
Insider Own 0.20%
Instit Own 81.49%
Short Float 4.04%
Short Ratio 5.45
Short Interest 12.02M
52W High 49.14
vs 52W High -3.68%
52W Low 35.70
vs 52W Low 32.58%
Beta 0.59
Impl. Vol. 22.96%
Rel Volume 1.65
Avg Volume 2.05M
Volume 3.39M
Target (mean) $49.94
Tgt Median $50.00
Tgt Low $43.00
Tgt High $59.00
# Analysts 16
Recom Buy
Prev Close $47.93
Price $47.33
Change -1.25%
About

Omega Healthcare Investors, Inc. is a Real Estate Investment Trust. The firm is providing financing and capital to the long-term healthcare industry in the United States and the United Kingdom with a focus on skilled nursing and assisted living facilities, including care homes in the United Kingdom. As of September 30, 2025, Omega has a portfolio of investments that includes 1,024 operating facilities located in 42 states, the District of Columbia and the United Kingdom/Jersey (290 facilities) and operated by 88 different operators. Additionally, Omega has investments in several unconsolidated entities that own 19 facilities. As a source of capital to the healthcare industry, Omega continually evaluates the opportunities, trends and challenges affecting the industry. Our goal is to identify long-term investments in quality healthcare properties with outstanding operators that provide the most favorable risk/reward ratio to our investors. Omega Healthcare Investors, Inc. is based in Hunt Valley, United States.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$49.94
Mean price target
2. Current target
$47.33
Latest analyst target
3. DCF / Fair value
$30.72
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$47.33
Low
$43.00
High
$59.00
Mean
$49.94

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2026-05-13 main UBS Buy → Buy $54
2026-05-04 main RBC Capital Sector Perform → Sector Perform $48
2026-05-01 main Citigroup Buy → Buy $52
2026-04-14 down B of A Securities Neutral → Underperform $46
2026-03-26 main Wells Fargo Equal-Weight → Equal-Weight $47
2026-03-05 main Truist Securities Hold → Hold $48
2026-03-02 main Scotiabank Sector Perform → Sector Perform $48
2026-02-10 main RBC Capital Sector Perform → Sector Perform $47
2026-02-10 main Cantor Fitzgerald Overweight → Overweight $52
2026-01-29 down Wells Fargo Overweight → Equal-Weight $45
2026-01-09 down BMO Capital Outperform → Market Perform $45
2026-01-08 main UBS Buy → Buy $51
2025-12-02 main Truist Securities Hold → Hold $46
2025-11-25 main Wells Fargo Overweight → Overweight $48
2025-11-18 init UBS — → Buy $50
2025-11-13 main Scotiabank Sector Perform → Sector Perform $45
2025-11-12 main Citigroup Buy → Buy $50
2025-11-06 main RBC Capital Sector Perform → Sector Perform $44
2025-10-21 main Wells Fargo Overweight → Overweight $45
2025-10-01 init Cantor Fitzgerald — → Overweight $50
News
RSS: Latest OHI news
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-04-01 BALLEW NEAL A. Officer — 168 $37.25 $6,258
2026-03-31 STEPHENSON ROBERT O Chief Financial Officer — 28,770 $43.82 $1,260,701
2026-03-31 MAKODE GAIL D Officer — 14,863 $43.82 $651,297
2026-03-31 BALLEW NEAL A. Officer — 14,863 $43.82 $651,297
2026-03-31 GOURMAND MATTHEW PAUL President — 14,863 $43.82 $651,297
2026-03-31 GUPTA VIKAS Chief Investment Officer — 14,863 $43.82 $651,297
2026-03-31 PICKETT C TAYLOR Chief Executive Officer — 69,226 $43.82 $3,033,483
2025-12-31 STEPHENSON ROBERT O Chief Financial Officer — 31,426 $0.00 $0
2025-12-31 BALLEW NEAL A. Officer — 173 $35.89 $6,209
2025-12-31 PICKETT C TAYLOR Chief Executive Officer — 60,459 $44.34 $2,680,752
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
1,190.10
+13.19%
1,051.39
+10.70%
949.74
+8.14%
878.24
Operating Revenue
1,177.08
+12.63%
1,045.12
+10.44%
946.28
+8.13%
875.15
Cost Of Revenue
14.44
-0.84%
14.56
-3.09%
15.03
-3.06%
15.50
Reconciled Cost Of Revenue
14.44
-0.84%
14.56
-3.09%
15.03
-3.06%
15.50
Gross Profit
1,175.66
+13.39%
1,036.83
+10.92%
934.72
+8.34%
862.74
Operating Expense
431.72
+14.46%
377.17
-15.38%
445.74
-5.26%
470.47
Selling General And Administration
104.14
+18.34%
88.00
+7.97%
81.50
+17.45%
69.40
General And Administrative Expense
104.14
+18.34%
88.00
+7.97%
81.50
+17.45%
69.40
Other Gand A
104.14
+18.34%
88.00
+7.97%
81.50
+17.45%
69.40
Total Expenses
446.16
+13.90%
391.73
-14.98%
460.77
-5.19%
485.97
Operating Income
743.94
+12.78%
659.66
+34.91%
488.97
+24.65%
392.28
EBITDA
1,164.71
+22.98%
947.11
+16.81%
810.84
-19.06%
1,001.79
Normalized EBITDA
1,119.25
+15.25%
971.14
+17.15%
828.95
+14.70%
722.69
Reconciled Depreciation
325.25
+6.76%
304.65
-4.70%
319.68
-3.83%
332.41
EBIT
839.47
+30.66%
642.46
+30.80%
491.16
-26.62%
669.38
Total Unusual Items
45.47
+289.24%
-24.03
-32.69%
-18.11
-106.49%
279.11
Total Unusual Items Excluding Goodwill
45.47
+289.24%
-24.03
-32.69%
-18.11
-106.49%
279.11
Special Income Charges
45.47
+289.24%
-24.03
-32.69%
-18.11
-106.49%
279.11
Other Special Charges
-5.00
-385.59%
1.75
+255.49%
0.49
+26.48%
0.39
Impairment Of Capital Assets
22.61
-5.12%
23.83
-74.08%
91.94
+139.12%
38.45
Restructuring And Mergern Acquisition
4.22
-63.68%
11.62
+117.47%
5.34
-87.29%
42.01
Write Off
—
—
0.00
0.00
Net Income
590.18
+45.25%
406.33
+67.78%
242.18
-43.27%
426.93
Pretax Income
624.43
+48.41%
420.75
+64.59%
255.63
-41.39%
436.14
Net Non Operating Interest Income Expense
-215.03
+3.01%
-221.72
+5.86%
-235.53
-0.98%
-233.24
Interest Expense Non Operating
215.03
-3.01%
221.72
-5.86%
235.53
+0.98%
233.24
Net Interest Income
-215.03
+3.01%
-221.72
+5.86%
-235.53
-0.98%
-233.24
Interest Expense
215.03
-3.01%
221.72
-5.86%
235.53
+0.98%
233.24
Other Income Expense
95.53
+655.36%
-17.20
-885.79%
2.19
-99.21%
277.11
Other Non Operating Income Expenses
50.06
+633.34%
6.83
-66.37%
20.30
+1116.37%
-2.00
Tax Provision
14.75
+35.83%
10.86
+73.59%
6.25
+37.14%
4.56
Tax Rate For Calcs
0.00
-8.48%
0.00
+5.47%
0.00
+133.97%
0.00
Tax Effect Of Unusual Items
1.07
+273.19%
-0.62
-39.94%
-0.44
-115.18%
2.92
Net Income Including Noncontrolling Interests
609.47
+45.87%
417.80
+67.93%
248.80
-43.31%
438.84
Net Income From Continuing Operation Net Minority Interest
590.18
+45.25%
406.33
+67.78%
242.18
-43.27%
426.93
Net Income From Continuing And Discontinued Operation
590.18
+45.25%
406.33
+67.78%
242.18
-43.27%
426.93
Net Income Continuous Operations
609.47
+45.87%
417.80
+67.93%
248.80
-43.31%
438.84
Minority Interests
-19.28
-67.99%
-11.48
-73.49%
-6.62
+44.47%
-11.91
Normalized Income
545.79
+27.01%
429.73
+65.38%
259.84
+72.38%
150.74
Net Income Common Stockholders
572.03
+40.78%
406.33
+67.78%
242.18
-43.27%
426.93
Otherunder Preferred Stock Dividend
18.16
—
—
—
Diluted EPS
1.94
+25.16%
1.55
+55.00%
1.00
-44.44%
1.80
Basic EPS
1.96
+24.84%
1.57
+55.45%
1.01
-44.20%
1.81
Basic Average Shares
291.65
+12.99%
258.12
+7.33%
240.49
+1.79%
236.26
Diluted Average Shares
304.95
+12.76%
270.45
+7.99%
250.45
+2.52%
244.29
Diluted NI Availto Com Stockholders
591.39
+41.35%
418.39
+67.85%
249.26
-43.20%
438.84
Average Dilution Earnings
19.36
+60.50%
12.06
+70.41%
7.08
-40.60%
11.91
Depreciation Amortization Depletion Income Statement
325.25
+6.76%
304.65
-4.70%
319.68
-3.83%
332.41
Depreciation And Amortization In Income Statement
325.25
+6.76%
304.65
-4.70%
319.68
-3.83%
332.41
Earnings From Equity Interest Net Of Tax
-0.22
-102.75%
7.92
+1460.14%
-0.58
-108.02%
7.26
Gain On Sale Of PPE
67.30
+411.11%
13.17
-83.47%
79.67
-77.87%
359.95
Provision For Doubtful Accounts
2.34
+115.09%
-15.48
-134.75%
44.56
-35.11%
68.66
Line Item Trend 2023-12-31
Total Assets
9,117.40
Current Assets
2,234.88
Cash Cash Equivalents And Short Term Investments
442.81
Cash And Cash Equivalents
442.81
Receivables
1,723.04
Accounts Receivable
223.42
Other Receivables
8.72
Accrued Interest Receivable
3.13
Loans Receivable
513.39
Restricted Cash
1.92
Assets Held For Sale Current
67.12
Total Non Current Assets
6,882.52
Goodwill And Other Intangible Assets
643.90
Goodwill
643.90
Investments And Advances
188.41
Long Term Equity Investment
188.41
Other Investments
—
Other Non Current Assets
147.69
Total Liabilities Net Minority Interest
5,355.11
Current Liabilities
308.19
Payables And Accrued Expenses
287.80
Current Accrued Expenses
287.80
Current Debt And Capital Lease Obligation
20.40
Current Debt
20.40
Total Non Current Liabilities Net Minority Interest
5,046.92
Long Term Debt And Capital Lease Obligation
5,046.92
Long Term Debt
5,046.92
Non Current Deferred Liabilities
—
Non Current Deferred Taxes Liabilities
—
Stockholders Equity
3,574.58
Common Stock Equity
3,574.58
Capital Stock
24.53
Common Stock
24.53
Preferred Stock
0.00
Share Issued
245.28
Ordinary Shares Number
245.28
Treasury Shares Number
0.00
Additional Paid In Capital
6,671.20
Retained Earnings
-3,150.48
Gains Losses Not Affecting Retained Earnings
29.34
Minority Interest
187.71
Other Equity Adjustments
29.34
Total Equity Gross Minority Interest
3,762.29
Total Capitalization
8,621.50
Working Capital
1,926.69
Invested Capital
8,641.90
Total Debt
5,067.32
Net Debt
4,624.51
Net Tangible Assets
2,930.69
Tangible Book Value
2,930.69
Investment Properties
5,902.53
Investmentsin Joint Venturesat Cost
188.41
Line Of Credit
20.40
Notes Receivable
974.39
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
878.55
+17.23%
749.43
+21.32%
617.74
-1.28%
625.73
Cash Flow From Continuing Operating Activities
878.55
+17.23%
749.43
+21.32%
617.74
-1.28%
625.73
Net Income From Continuing Operations
609.47
+45.87%
417.80
+67.93%
248.80
-43.31%
438.84
Depreciation Amortization Depletion
325.25
+6.76%
304.65
-4.70%
319.68
-3.83%
332.41
Depreciation And Amortization
325.25
+6.76%
304.65
-4.70%
319.68
-3.83%
332.41
Other Non Cash Items
-75.57
-133.18%
-32.41
+12.40%
-37.00
+27.79%
-51.24
Stock Based Compensation
44.19
+20.42%
36.70
+4.64%
35.07
+28.44%
27.30
Provisionand Write Offof Assets
30.32
+368.10%
-11.31
-117.35%
65.19
-66.30%
193.42
Asset Impairment Charge
22.61
-5.12%
23.83
-74.08%
91.94
+139.12%
38.45
Operating Gains Losses
-61.17
-445.13%
-11.22
+85.88%
-79.49
+77.89%
-359.50
Gain Loss On Investment Securities
-67.30
-411.11%
-13.17
+83.47%
-79.67
+77.87%
-359.95
Change In Working Capital
-2.95
-108.97%
32.85
+317.65%
-15.10
-197.64%
15.46
Change In Receivables
2.89
+441.78%
-0.84
+76.91%
-3.66
-220.75%
3.03
Changes In Account Receivables
2.89
+441.78%
-0.84
+76.91%
-3.66
-220.75%
3.03
Change In Other Working Capital
3.21
-90.50%
33.76
+794.30%
3.77
-41.67%
6.47
Change In Other Current Assets
-9.04
-14724.59%
-0.06
+99.60%
-15.21
-355.33%
5.96
Investing Cash Flow
-539.79
+19.57%
-671.16
-87064.16%
-0.77
-100.17%
442.85
Cash Flow From Continuing Investing Activities
-539.79
+19.57%
-671.16
-87064.16%
-0.77
-100.17%
442.85
Net PPE Purchase And Sale
—
—
0.00
0.00
Purchase Of PPE
—
—
—
—
Sale Of PPE
—
—
0.00
0.00
Capital Expenditure
—
—
—
—
Net Investment Purchase And Sale
4.24
-49.70%
8.43
-25.92%
11.38
0.00
Purchase Of Investment
—
—
—
—
Sale Of Investment
4.24
-49.70%
8.43
-25.92%
11.38
0.00
Net Business Purchase And Sale
-122.09
-12473.43%
-0.97
+92.14%
-12.35
-10829.20%
-0.11
Purchase Of Business
-122.09
-12473.43%
-0.97
+92.14%
-12.35
-10829.20%
-0.11
Net Other Investing Changes
79.85
+130.79%
-259.32
-4.28%
-248.68
-891.89%
-25.07
Financing Cash Flow
-838.26
-3284.98%
26.32
+105.56%
-473.31
+40.05%
-789.45
Cash Flow From Continuing Financing Activities
-838.26
-3284.98%
26.32
+105.56%
-473.31
+40.05%
-789.45
Net Issuance Payments Of Debt
-585.05
-20.01%
-487.48
-113.88%
-227.92
-2910.00%
8.11
Issuance Of Debt
1,311.71
+99.40%
657.82
+29.73%
507.07
-15.12%
597.40
Repayment Of Debt
-1,896.76
-65.61%
-1,145.30
-55.83%
-734.99
-24.72%
-589.29
Long Term Debt Issuance
1,311.71
+99.40%
657.82
+29.73%
507.07
-15.12%
597.40
Long Term Debt Payments
-1,896.76
-65.61%
-1,145.30
-55.83%
-734.99
-24.72%
-589.29
Net Long Term Debt Issuance
-585.05
-20.01%
-487.48
-113.88%
-227.92
-2910.00%
8.11
Net Common Stock Issuance
609.14
-50.70%
1,235.66
+267.32%
336.40
+350.76%
-134.16
Common Stock Payments
—
0.00
0.00
+100.00%
-142.27
Common Stock Dividend Paid
-780.39
-13.85%
-685.45
-6.46%
-643.87
-1.73%
-632.89
Cash Dividends Paid
-780.39
-13.85%
-685.45
-6.46%
-643.87
-1.73%
-632.89
Repurchase Of Capital Stock
—
0.00
0.00
+100.00%
-142.27
Net Other Financing Charges
-81.96
-125.10%
-36.41
-158.66%
62.07
+303.45%
-30.51
Changes In Cash
-499.50
-577.60%
104.58
-27.20%
143.66
-48.53%
279.13
Effect Of Exchange Rate Changes
5.33
+1018.10%
-0.58
-234.88%
0.43
+114.83%
-2.90
Beginning Cash Position
548.74
+23.39%
444.73
+47.93%
300.64
+1131.59%
24.41
End Cash Position
54.56
-90.06%
548.74
+23.39%
444.73
+47.93%
300.64
Free Cash Flow
878.55
+17.23%
749.43
+21.32%
617.74
-1.28%
625.73
Interest Paid Supplemental Data
224.05
-3.01%
230.99
-1.48%
234.45
+6.21%
220.75
Income Tax Paid Supplemental Data
4.31
-48.75%
8.41
+132.75%
3.62
-37.60%
5.79
Common Stock Issuance
609.14
-50.70%
1,235.66
+267.32%
336.40
+4046.97%
8.11
Dividends Received CFI
12.91
+1169.71%
1.02
-88.45%
8.81
+164.63%
3.33
Earnings Losses From Equity Investments
6.13
+215.05%
1.95
+969.78%
0.18
-60.00%
0.46
Interest Paid CFO
-13.59
-18.56%
-11.46
-0.86%
-11.37
-20.61%
-9.42
Issuance Of Capital Stock
609.14
-50.70%
1,235.66
+267.32%
336.40
+4046.97%
8.11
Net Investment Properties Purchase And Sale
-514.71
-22.46%
-420.32
-275.08%
240.07
-48.34%
464.71
Purchase Of Investment Properties
-797.49
-54.74%
-515.37
-49.40%
-344.96
-17.20%
-294.34
Sale Of Investment Properties
282.78
+197.52%
95.05
-83.75%
585.03
-22.93%
759.05
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category